The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Quest Partners LLC

Quest Partners LLC trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 96.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 623 shares of the medical device company’s stock after selling 18,675 shares during the quarter. Quest Partners LLC’s holdings in Cooper Companies were worth $69,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of Cooper Companies by 3.0% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company’s stock worth $682,738,000 after purchasing an additional 231,155 shares in the last quarter. Victory Capital Management Inc. grew its position in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares in the last quarter. Impax Asset Management Group plc increased its stake in Cooper Companies by 31.0% during the 2nd quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock valued at $205,511,000 after buying an additional 558,886 shares during the period. Swedbank AB raised its position in shares of Cooper Companies by 16.6% during the 2nd quarter. Swedbank AB now owns 1,600,420 shares of the medical device company’s stock worth $139,717,000 after buying an additional 228,000 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Cooper Companies by 12.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,341,944 shares of the medical device company’s stock worth $117,156,000 after acquiring an additional 148,500 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Up 1.0 %

Shares of COO opened at $104.46 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The company has a 50-day simple moving average of $105.18 and a 200-day simple moving average of $98.60. The Cooper Companies, Inc. has a 52 week low of $82.21 and a 52 week high of $112.38. The firm has a market capitalization of $20.80 billion, a P/E ratio of 58.19, a P/E/G ratio of 2.24 and a beta of 0.99.

Cooper Companies (NASDAQ:COOGet Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. During the same quarter in the prior year, the firm posted $0.84 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Piper Sandler raised their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Robert W. Baird lifted their price target on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Wells Fargo & Company lifted their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Wednesday. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Get Our Latest Analysis on COO

Insider Transactions at Cooper Companies

In other Cooper Companies news, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the sale, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. The trade was a 78.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. This represents a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Recommended Stories

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.